(33 days)
Neuro II-SE, Neuro II-S, Siemens Magnetom Espree 1.5T MRI System
Not Found
No
The description focuses on the mechanical and traditional MRI functionalities, with no mention of AI/ML terms or data processing beyond standard image acquisition.
No
The device is strictly described as a diagnostic imaging device, producing images for interpretation by a physician to aid in diagnosis, and does not mention any therapeutic capabilities.
Yes
The "Intended Use / Indications for Use" section explicitly states "The Neuro II-SE is intended for use as a diagnostic patient imaging device."
No
The device description explicitly lists hardware components such as the MRI system assembly, magnet mover assembly, OR Table assembly, Head Fixation Device, and Intra-operative Coil.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The IMRIS Neuro II-SE MRI system is an imaging device that produces images of the inside of the body using magnetic resonance. It does not analyze samples taken from the body.
- Intended Use: The intended use clearly states it's a "diagnostic patient imaging device" that produces "tomographic cross-sectional images" of the body's soft tissue structure. This is consistent with in-vivo imaging, not in-vitro testing.
Therefore, the IMRIS Neuro II-SE MRI system falls under the category of medical imaging devices rather than In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
The IMRIS Neuro II-SE MRI system is indicated for use for the head and whole body.
The Neuro II-SE is intended for use as a diagnostic patient imaging device. This device produces tomographic cross-sectional images that:
- correspond to the distribution of protons exhibiting MR characteristics; し、
- depend upon NMR parameters (proton density, flow velocity, spin-lattice relaxation time (T1) and 2. spin-spin relaxation time (T2); and
- display the soft tissue structure of the head and whole body. 3.
When interpreted by a trained physician, these images vield information that can be useful in the determination of a diagnosis.
The Neuro II-SE may be used during intra-operative procedures when performed in an intra-operative MRI suite with MR compatible devices such as anesthesia and patient monitoring equipment.
The Neuro II-SE may also be used for imaging in a multi-room suite.
Product codes
LNH
Device Description
The Neuro II-SE system is a traditional MRI unit that has been suspended on an overhead rail system to facilitate intra-operative use. The main components of the Neuro II-SE system are the MRI system assembly (including diagnostic RF coils), the magnet mover assembly, the OR Table assembly, Head Fixation Device and the Intra-operative Coil.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
MRI
Anatomical Site
head and whole body
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained physician, intra-operative MRI suite, multi-room suite
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Laboratory testing has been completed to verify the equivalence to the Siemens Magnetom Espree System and to verify the safe and effective intra-operative operation of the Neuro II-SE (OR-DR-OR/OR-MB configurations).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Neuro II-SE, Neuro II-S, Siemens Magnetom Espree 1.5T MRI System
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1000 Magnetic resonance diagnostic device.
(a)
Identification. A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).(b)
Classification. Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
510(K) SUMMARY OF SAFETY AND EFFECTIVENESS (AS REQUIRED BY 21 CFR 807.92)
1. GENERAL INFORMATION
MAY 2 2 2007
| Establishment: | IMRIS Inc. |
|---|---|
| Address: | 100-1370 Sony Place |
| Winnipeg, Manitoba | |
| Canada | |
| R3T 1N5 | |
| Registration Number: | 3003807210 |
| Contact Person: | Mrs. B. Newis |
| Quality Assurance Representative | |
| email: bnewis@imris.com | |
| Phone: 1-204-480-7070 ext.7043 | |
| Fax: 1-204-480-7071 | |
| Date of Summary Preparation: | April 17, 2007 |
| Device Name: | Neuro II-SE Intra-operative Imaging System |
| Trade Name: | Neuro II-SE |
| Common Name: | MRDD (Magnetic Resonance Diagnostic Device) |
| Proprietary name: | Neuro II-SE |
| Classification name: | System, Nuclear Magnetic Resonance Imaging |
| Classification: | 21 CFR 892.1000 |
| Class: | Class II |
| Product Code: | LNH (Magnetic Resonance Imaging System) |
| Performance Standards: | None established under Section 514 of the Food, Drug and Cosmetic Act |
INDICATIONS FOR USE 2.
The IMRIS Neuro II-SE MRI system is indicated for use for the head and whole body.
3. INTENDED USE OF THE DEVICE
The Neuro II-SE is intended for use as a diagnostic patient imaging device. This device produces tomographic cross-sectional images that:
- correspond to the distribution of protons exhibiting MR characteristics; し、
- depend upon NMR parameters (proton density, flow velocity, spin-lattice relaxation time (T1) and 2. spin-spin relaxation time (T2); and
- display the soft tissue structure of the head and whole body. 3.
When interpreted by a trained physician, these images vield information that can be useful in the determination of a diagnosis.
The Neuro II-SE may be used during intra-operative procedures when performed in an intra-operative MRI suite with MR compatible devices such as anesthesia and patient monitoring equipment.
The Neuro II-SE may also be used for imaging in a multi-room suite.
1
DEVICE DESCRIPTION 4.
The Neuro II-SE system is a traditional MRI unit that has been suspended on an overhead rail system to facilitate intra-operative use. The main components of the Neuro II-SE system are the MRI system assembly (including diagnostic RF coils), the magnet mover assembly, the OR Table assembly, Head Fixation Device and the Intra-operative Coil.
SAFETY AND EFFECTIVENESS 5.
The Neuro II-SE (OR-DR-OR/OR-MB configurations) have been designed to provide MRI imaging in an intra-operative setting in the same manner as the predicate Neuro II -- SE System and predicate Neuro II-S devices, The Neuro II-SE's (OR-DR-OR/OR-MB configurations) intra-operative features, including the Magnet Mover Assembly, OR Patient Table, Intra-operative Coil and Head Fixation Device are substantially equivalent to the same intra-operative features of the predicate Neuro II-SE and predicate Neuro II-S. The Neuro II-SE (OR-DR-OR/OR-MB configurations) does not raise any new safety or effectiveness issues related to the use of a moving MRI system in an intra-operative setting.
The Neuro II-SE's (OR-DR-OR/OR-MB configurations) MRI imaging system's software and hardware are substantially equivalent to the Siemens Magnetom Espree 1.5T MRI System. The Neuro II-SE does not raise any new safety issues related to static magnetic field effects, changing magnetic field effects, RF heating or acoustic noise or effectiveness issues related to specification volume, signal to noise, image uniformity, and geometric distortion, slice profile, thickness and gap, or high contrast spatial resolution.
Laboratory testing has been completed to verify the equivalence to the Siemens Magnetom Espree System and to verify the safe and effective intra-operative operation of the Neuro II-SE (OR-DR-OR/OR-MB configurations).
The Neuro II-SE (OR-DR-OR/OR-MB configurations) Intra-operative Magnetic Resonance Imaging System is substantially equivalent to the Siemens Magnetom Espree; the IMRIS predicate Neuro II-SE and the predicate Neuro II-S imaging systems.
2
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" written around it. Inside the circle is an abstract symbol that resembles an eagle or bird in flight, composed of three curved lines.
Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850
MAY 2 2 2007
IMRIS, Inc. c/o Mr. Thomas M. Tsakeris President Devices & Diagnostics Consulting Group, Inc. 16809 Briardale Road ROCKVILLE MD 20855
K071099 Re:
Trade/Device Name: Neuro II-SE Intra-operative Magnetic Resonance Imaging System Regulation Number: 21 CFR §892.1000 Regulation Name: Magnetic resonance diagnostic device Regulatory Class: II Product Code: LNH Dated: April 16, 2007 Received: April 19, 2007
Dear Mr. Tsakeris:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Image /page/2/Picture/10 description: The image is a circular logo with the letters "FDA" in a stylized font in the center. Above the letters, the years "1906-2006" are printed. Below the letters, the word "Centennial" is printed in a cursive font, followed by three stars. The text "U.S. FOOD & DRUG ADMINISTRATION" is printed around the border of the circle.
Protecting and Promoting Public Health
3
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with allthe Act's requirements, including, but not limited to registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:
| 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 |
|---|---|---|
| 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 |
| 21 CFR 892.xxxx | (Radiology) | 240-276-0120 |
| Other | 240-276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address
http://www.fda.gov/cdrh/industry/support/index.html
Sincerely yours.
Nancy C. Brogdon
Nancy C. Brogdon Director. Division of Reproductive. Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
6-0115
Enclosure
4
Indications for Use Statement
| Ver/ 3 - 4/24/96 | |
|---|---|
| Applicant: | IMRIS Inc. |
| Device Name: | Neuro II-SE Intra-operative Magnetic Resonance Imaging System |
Indications For Use:
The IMRIS Neuro II-SE MRI system is indicated for use for the head and whole body.
The Neuro II-SE is intended for use as a diagnostic patient imaging device. This device produces
tomographic cross-sectional images that:
- correspond to the distribution of protons exhibiting MR characteristics;
- depend upon NMR parameters (proton density, flow velocity, spin-lattice relaxation time (T1) and
spin-spin relaxation time (T2); and - display the soft tissue structure of the body.
When interpreted by a trained physician, these images yield information that can be useful in the
determination of a diagnosis.
The Neuro II-SE may also be used during intra-operative procedures when performed in an intra-
operative MRI suite with MR compatible devices such as anesthesia and patient monitoring equipment.
The Neuro II-SE may also be used in a multi-room suite.
(Division Sign-Off)
Division of Reproductive, Abdominal,
and Radiological Devices
510(k) Number: 2071099
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Per 21 CFR 801.109)
(Optional Format 1-2-96)
.
: